Cargando…

Multiple drugs: Atrial fibrillation, Bradycardia, QTC interval prolongation and off label use: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569089/ http://dx.doi.org/10.1007/s40278-021-05088-z

Ejemplares similares

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Multiple drugs: QTc interval prolongation following off-label use: 5 case reports
Publicado: (2022)

Multiple drugs: Off label use and QTc prolongation: case report
Publicado: (2021)

Multiple drugs: QTc prolongation and off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Hydroxychloroquine: Borderline prolongation of QTc interval during off-label treatment: case report
Publicado: (2020)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Multiple drugs: QTc prolongation, lack of efficacy and off-label use: 3 case reports
Publicado: (2021)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Multiple drugs: QTc prolongation leading to torsades-de-pointes and off-label use: case report
Publicado: (2021)

Multiple drug interactions: QTc time prolongation following off-label use: 3 case reports
Publicado: (2022)

Multiple drugs: QTc prolongation, hyperglycaemia, off label use and drug exposure during pregnancy: case report
Publicado: (2021)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Antibacterials/antivirals: QTc-interval prolongation and cardiac arrest following off-label therapy: 3 case reports
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Vomiting and QTc-interval prolongation following off-label therapy: 2 case reports
Publicado: (2021)

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports
Publicado: (2020)

Hydroxychloroquine: Acute kidney injury, prolonged QTC interval and renal phospholipidosis following off-label use: case report
Publicado: (2021)

Chloroquine/dalteparin sodium/hydroxycarbamide: Prolongation of the QTc interval secondary to off-label use and lack of efficacy: case report
Publicado: (2021)

Chloroquine: QTc interval prolongation leading to frequent extrasystoles and ventricular tachycardia following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Atazanavir/ritonavir: QTc prolongation following off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Methadone abuse: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Multiple drugs: Bradycardia, atrioventricular block and off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Persistent increase in QTc interval following off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Ticagrelor-Induced Prolongation of the QTc Interval
por: Ray, Avik, et al.
Publicado: (2019)

Hydroxychloroquine: Right bundle branch block and QTc prolongation following off label use: case report
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Multiple drugs: QTc prolongation and torsades de pointes: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8uhnu07nac72vk11b9b33q1kc3